{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:49:18Z","timestamp":1790099358441,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020477","name":"Edward Via College of Osteopathic Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020477","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jpet.2026.104787","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:29:47Z","timestamp":1775633387000},"page":"104787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nonrodent safety and pharmacokinetics supporting clinical development of a novel N-methyl-D-aspartate receptor modulator (CNS4)"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6151-2251","authenticated-orcid":false,"given":"Blaise M.","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7930-4589","authenticated-orcid":false,"given":"Jennifer L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7956-4717","authenticated-orcid":false,"given":"De\u2019Yana N.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0422-3984","authenticated-orcid":false,"given":"Ramu","family":"Anandakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1516-3841","authenticated-orcid":false,"given":"Joanne","family":"Tuohy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jpet.2026.104787_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/AJP.0000000000000547","article-title":"A systematic review of NMDA receptor antagonists for treatment of neuropathic pain in clinical practice","volume":"34","author":"Aiyer","year":"2018","journal-title":"Clin J Pain"},{"issue":"1","key":"10.1016\/j.jpet.2026.104787_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpa.2006.12.006","article-title":"The clinical role of NMDA receptor antagonists for the treatment of postoperative pain","volume":"21","author":"De Kock","year":"2007","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104787_bib3","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1213\/01.ANE.0000081061.12235.55","article-title":"The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review","volume":"97","author":"Petrenko","year":"2003","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.jpet.2026.104787_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.jpet.2026.104787_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"10.1016\/j.jpet.2026.104787_bib6","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1523\/JNEUROSCI.3703-08.2009","article-title":"Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine","volume":"29","author":"Kotermanski","year":"2009","journal-title":"J Neurosci"},{"issue":"4\u20136","key":"10.1016\/j.jpet.2026.104787_bib7","first-page":"365","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.jpet.2026.104787_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1113\/jphysiol.1991.sp018565","article-title":"Persistent pulsatile release of glutamate induced by N-methyl-D-aspartate in neonatal rat hippocampal neurones","volume":"436","author":"Cherubini","year":"1991","journal-title":"J Physiol"},{"key":"10.1016\/j.jpet.2026.104787_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fnsys.2011.00094","article-title":"Extracellular glutamate: functional compartments operate in different concentration ranges","volume":"5","author":"Moussawi","year":"2011","journal-title":"Front Syst Neurosci"},{"issue":"13","key":"10.1016\/j.jpet.2026.104787_bib10","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1523\/JNEUROSCI.19-13-05265.1999","article-title":"The concentration of synaptically released glutamate outside of the climbing fiber-Purkinje cell synaptic cleft","volume":"19","author":"Dzubay","year":"1999","journal-title":"J Neurosci"},{"issue":"5087","key":"10.1016\/j.jpet.2026.104787_bib11","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1126\/science.1359647","article-title":"The time course of glutamate in the synaptic cleft","volume":"258","author":"Clements","year":"1992","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jpet.2026.104787_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-2236(96)10024-2","article-title":"Transmitter timecourse in the synaptic cleft: its role in central synaptic function","volume":"19","author":"Clements","year":"1996","journal-title":"Trends Neurosci"},{"issue":"12","key":"10.1016\/j.jpet.2026.104787_bib13","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1523\/JNEUROSCI.17-12-04672.1997","article-title":"Transporters buffer synaptically released glutamate on a submillisecond time scale","volume":"17","author":"Diamond","year":"1997","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.jpet.2026.104787_bib14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"10.1016\/j.jpet.2026.104787_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.859","article-title":"A glutamate concentration-biased allosteric modulator potentiates NMDA-induced ion influx in neurons","volume":"9","author":"Costa","year":"2021","journal-title":"Pharmacol Res Perspect"},{"issue":"4","key":"10.1016\/j.jpet.2026.104787_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103401","article-title":"Preliminary pharmacokinetics and in vivo studies indicate analgesic and stress mitigation effects of a novel NMDA receptor modulator","volume":"392","author":"Costa","year":"2025","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2026.104787_bib17","series-title":"Biased nmda receptor modulators and uses thereof [Internet]","author":"Costa","year":"2018"},{"issue":"3","key":"10.1016\/j.jpet.2026.104787_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1107","article-title":"CNS4 causes subtype-specific changes in agonist efficacy and reversal potential of permeant cations in NMDA receptors","volume":"11","author":"Boehringer","year":"2023","journal-title":"Pharmacol Res Perspect"},{"issue":"2","key":"10.1016\/j.jpet.2026.104787_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41589-019-0449-5","article-title":"Biased modulators of NMDA receptors control channel opening and ion selectivity","volume":"16","author":"Perszyk","year":"2020","journal-title":"Nat Chem Biol"},{"issue":"38","key":"10.1016\/j.jpet.2026.104787_bib20","doi-asserted-by":"crossref","first-page":"14975","DOI":"10.1523\/JNEUROSCI.3109-13.2013","article-title":"A prominent role for triheteromeric GluN1\/GluN2A\/GluN2B NMDARs at central synapses","volume":"33","author":"Soares","year":"2013","journal-title":"J Neurosci"},{"issue":"21","key":"10.1016\/j.jpet.2026.104787_bib21","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1523\/JNEUROSCI.0829-13.2013","article-title":"Triheteromeric NMDA receptors at hippocampal synapses","volume":"33","author":"Tovar","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpet.2026.104787_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cophys.2017.12.004","article-title":"Triheteromeric NMDA receptors: from structure to synaptic physiology","volume":"2","author":"Stroebel","year":"2018","journal-title":"Curr Opin Physiol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104787_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1460-9568.2002.02124.x","article-title":"Akt mediates the anti-apoptotic effect of NMDA but not that induced by potassium depolarization in cultured cerebellar granule cells","volume":"16","author":"Lafon-Cazal","year":"2002","journal-title":"Eur J Neurosci"},{"issue":"17","key":"10.1016\/j.jpet.2026.104787_bib24","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1523\/JNEUROSCI.5019-04.2005","article-title":"Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection","volume":"25","author":"Papadia","year":"2005","journal-title":"J Neurosci"},{"issue":"21","key":"10.1016\/j.jpet.2026.104787_bib25","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.286.21.2673","article-title":"Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial","volume":"286","author":"Albers","year":"2001","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jpet.2026.104787_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(02)00164-3","article-title":"Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?","volume":"1","author":"Ikonomidou","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpet.2026.104787_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108840","article-title":"Differential regulation of STP, LTP and LTD by structurally diverse NMDA receptor subunit-specific positive allosteric modulators","volume":"202","author":"France","year":"2022","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.jpet.2026.104787_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41386-023-01614-3","article-title":"Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry","volume":"49","author":"Hanson","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpet.2026.104787_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"issue":"4","key":"10.1016\/j.jpet.2026.104787_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1939-1676.1998.tb02121.x","article-title":"Use of body surface area (BSA)-based dosages to calculate chemotherapeutic drug dose in dogs: I. potential problems with current BSA formulae","volume":"12","author":"Price","year":"1998","journal-title":"J Vet Intern Med"},{"issue":"5","key":"10.1016\/j.jpet.2026.104787_bib31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jps.2600710516","article-title":"Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans","volume":"71","author":"Clements","year":"1982","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jpet.2026.104787_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1498945","article-title":"MONSTROUS: a web-based chemical-transporter interaction profiler","volume":"16","author":"AbdulHameed","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2026.104787_bib33","series-title":"Aulton\u2019s Pharmaceutics: The Design and Manufacture of Medicines","author":"Aulton","year":"2013"},{"issue":"2","key":"10.1016\/j.jpet.2026.104787_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijpharm.2013.06.004","article-title":"Statistical analysis of the effects of polyethylene glycol concentration and molecular weight on the sedimentation and resuspendability behavior of model aqueous dispersions","volume":"453","author":"Zhu","year":"2013","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1016\/j.jpet.2026.104787_bib35","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","article-title":"Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis","volume":"98","author":"Kaser","year":"2001","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.jpet.2026.104787_bib36","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.3390\/ijms22179250","article-title":"Evaluation of loco-regional skin toxicity induced by an in situ forming depot after a single subcutaneous injection at different volumes and flow rates in G\u00f6ttingen minipigs","volume":"22","author":"Peloso","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526009869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526009869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:05:11Z","timestamp":1779955511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526009869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0022356526009869"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104787","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonrodent safety and pharmacokinetics supporting clinical development of a novel N-methyl-D-aspartate receptor modulator (CNS4)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104787"}}